Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classifications

Tian Ye; Benjamin Tura; Ben Abbotts; Maurice P. Zeegers; K. K. Cheng; Nicholas D. James; Richard T. Bryan

doi:10.1111/bju.70247

Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classifications

Tian Ye
, Benjamin Tura
, Ben Abbotts
, Maurice P. Zeegers
, K. K. Cheng
, Nicholas D. James
, Richard T. Bryan^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Downloads (Pure)

Original language	English
Number of pages	3
Journal	BJU international
Early online date	23 Mar 2026
DOIs	https://doi.org/10.1111/bju.70247
Publication status	E-pub ahead of print - 23 Mar 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

clincial outcomes
European Association of Urology
Bacillus Calmette‐Guérin
risk stratification
BCG
Non‐muscle‐invasive bladder cancer
progression

Access to Document

10.1111/bju.70247Licence: Creative Commons: Attribution (CC BY)

YeT2026ClinicalFinal published version, 382 KBLicence: Creative Commons: Attribution (CC BY)

The West Midlands Bladder Cancer Prognosis Programme: rationale and design.
Zeegers, M., Bryan, R., Langford, C., Billingham, L., Murray, P., Deshmukh, N., Hussain, S., James, N., Wallace, D. & Cheng, K., 14 Sept 2009, In: BJU international. 105, 6, p. 784-788 5 p.
Research output: Contribution to journal › Article
42 Citations (Scopus)

Bladder Cancer Prognosis Programme
Ward, D. (Co-Investigator), Bryan, R. (Principal Investigator) & Arnold, R. (Co-Investigator)
Cancer Research UK
1/09/22 → 30/06/24
Project: Research

Cite this

@article{d38e01555e89409493ca6a80e170c6bd,

title = "Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classifications",

keywords = "clincial outcomes, European Association of Urology, Bacillus Calmette‐Gu{\'e}rin, risk stratification, BCG, Non‐muscle‐invasive bladder cancer, progression",

author = "Tian Ye and Benjamin Tura and Ben Abbotts and Zeegers, \{Maurice P.\} and Cheng, \{K. K.\} and James, \{Nicholas D.\} and Bryan, \{Richard T.\}",

year = "2026",

month = mar,

day = "23",

doi = "10.1111/bju.70247",

language = "English",

journal = "BJU international",

issn = "1464-4096",

publisher = "Wiley",

}

TY - JOUR

T1 - Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classifications

AU - Ye, Tian

AU - Tura, Benjamin

AU - Abbotts, Ben

AU - Zeegers, Maurice P.

AU - Cheng, K. K.

AU - James, Nicholas D.

AU - Bryan, Richard T.

PY - 2026/3/23

Y1 - 2026/3/23

KW - clincial outcomes

KW - European Association of Urology

KW - Bacillus Calmette‐Guérin

KW - risk stratification

KW - BCG

KW - Non‐muscle‐invasive bladder cancer

KW - progression

U2 - 10.1111/bju.70247

DO - 10.1111/bju.70247

M3 - Letter

SN - 1464-4096

JO - BJU international

JF - BJU international

ER -

Clinical outcomes of BCG-treated patients with high-risk non-muscle-invasive bladder cancer according to pre- and post-2021 European Association of Urology risk classifications

UN SDGs

Keywords

Access to Document

Fingerprint

Research output

The West Midlands Bladder Cancer Prognosis Programme: rationale and design.

Projects

Bladder Cancer Prognosis Programme

Cite this